Nanodrug Delivery Systems for the Treatment of Ovarian Cancer
Despite advances achieved in medicine, chemotherapeutics still has detrimental side effects with ovarian cancer (OC), accounting for numerous deaths among females. The provision of safe, early detection and active treatment of OC remains a challenge, in spite of improvements in new antineoplastic di...
Main Authors: | Jonathan M. Pantshwa, Pierre P. D. Kondiah, Yahya E. Choonara, Thashree Marimuthu, Viness Pillay |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/1/213 |
Similar Items
-
Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting
by: Jonathan M. Pantshwa, et al.
Published: (2018-10-01) -
Nanotechnology-Based Biopolymeric Oral Delivery Platforms for Advanced Cancer Treatment
by: Vanessa T. Chivere, et al.
Published: (2020-02-01) -
A 3D Bioprinted Pseudo-Bone Drug Delivery Scaffold for Bone Tissue Engineering
by: Pariksha Jolene Kondiah, et al.
Published: (2020-02-01) -
Recent Advances in Nanomicelles Delivery Systems
by: Salah M. Tawfik, et al.
Published: (2021-12-01) -
Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
by: Sulltana Jahan, et al.
Published: (2021-01-01)